Abstract
Background: Motor neuron disease (MND) invariably impacts on inspiratory muscle strength leading to respiratory failure. Regular assessment of sniff nasal inspiratory pressure (SNIP) and/or maximal mouth inspiratory pressure (MIP) contributes to early detection of a requirement for ventilatory support. Objectives: The aim of this study was to compare the feasibility, agreement, and performance of both tests in MND. Methods: Patients with MND followed by a multidisciplinary consultation were prospectively included. Pulmonary follow-up included forced expiratory volumes, vital capacity (VC) seated and supine, MIP, SNIP, pulse oximetry, and daytime arterial blood gases. Results: A total of 61 patients were included. SNIP and MIP could not be performed in 14 (21%) subjects; 74% of the subjects showed a decrease in MIP or SNIP at inclusion versus 31% for VC. Correlation between MIP and SNIP (Pearson’s rho: 0.68, p < 0.001) was moderate, with a non-significant bias in favor of SNIP (3.6 cm H2O) and wide limits of agreement (–34 to 41 cm H2O). Results were similar in “bulbar” versus “non-bulbar” patients. At different proposed cut-off values for identifying patients at risk of respiratory failure, the agreement between MIP and SNIP (64–79%) and kappa values (0.29–0.53) was moderate. Conclusions: MIP and SNIP were equally feasible. There was no significant bias in favor of either test, but a considerable disparity in results between tests, suggesting that use of both tests is warranted to screen for early detection of patients at risk of respiratory failure and avoid over diagnoses. SNIP, MIP, and VC all follow a relatively linear downhill course with a steeper slope for “bulbar” versus “non-bulbar” patients.
References
1.
Just
N
, Bautin
N
, Danel-Brunaud
V
, Debroucker
V
, Matran
R
, Perez
T
. The Borg dyspnoea score: a relevant clinical marker of inspiratory muscle weakness in amyotrophic lateral sclerosis
. Eur Respir J
. 2010
Feb
;35
(2
):353
–60
.
[PubMed]
0903-19362.
Similowski
T
, Attali
V
, Bensimon
G
, Salachas
F
, Mehiri
S
, Arnulf
I
, et al Diaphragmatic dysfunction and dyspnoea in amyotrophic lateral sclerosis
. Eur Respir J
. 2000
Feb
;15
(2
):332
–7
.
[PubMed]
0903-19363.
Heritier Barras
AC
, Adler
D
, Iancu Ferfoglia
R
, Ricou
B
, Gasche
Y
, Leuchter
I
, et al; CeSLA group
. Is tracheostomy still an option in amyotrophic lateral sclerosis? Reflections of a multidisciplinary work group
. Swiss Med Wkly
. 2013
Aug
;143
:w13830
.
[PubMed]
1424-78604.
Fromageot
C
, Lofaso
F
, Annane
D
, Falaize
L
, Lejaille
M
, Clair
B
, et al Supine fall in lung volumes in the assessment of diaphragmatic weakness in neuromuscular disorders
. Arch Phys Med Rehabil
. 2001
Jan
;82
(1
):123
–8
.
[PubMed]
0003-99935.
Allen
SM
, Hunt
B
, Green
M
. Fall in vital capacity with posture
. Br J Dis Chest
. 1985
Jul
;79
(3
):267
–71
.
[PubMed]
0007-09716.
Center
NN
. Motor Neurone Disease: assessment and mangement. Nice guideline NG42
. National Institute for Health and Care Excellence
; 2016
.7.
Goldberg
A
. Clinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD, and nocturnal hypoventilation—a consensus conference report
. Chest
. 1999
Aug
;116
(2
):521
–34
.
[PubMed]
0012-36928.
Andersen
PM
, Abrahams
S
, Borasio
GD
, de Carvalho
M
, Chio
A
, Van Damme
P
, et al; EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis
. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)—revised report of an EFNS task force
. Eur J Neurol
. 2012
Mar
;19
(3
):360
–75
.
[PubMed]
1351-51019.
Santos
DB
, Desmarais
G
, Falaize
L
, Ogna
A
, Cognet
S
, Louis
B
, et al Twitch mouth pressure for detecting respiratory muscle weakness in suspicion of neuromuscular disorder
. Neuromuscul Disord
. 2017
Jun
;27
(6
):518
–25
.
[PubMed]
0960-896610.
Lyall
RA
, Donaldson
N
, Polkey
MI
, Leigh
PN
, Moxham
J
. Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis
. Brain
. 2001
Oct
;124
(Pt 10
):2000
–13
.
[PubMed]
0006-895011.
Morgan
RK
, McNally
S
, Alexander
M
, Conroy
R
, Hardiman
O
, Costello
RW
. Use of Sniff nasal-inspiratory force to predict survival in amyotrophic lateral sclerosis
. Am J Respir Crit Care Med
. 2005
Feb
;171
(3
):269
–74
.
[PubMed]
1073-449X12.
Polkey
MI
, Lyall
RA
, Yang
K
, Johnson
E
, Leigh
PN
, Moxham
J
. Respiratory Muscle Strength as a Predictive Biomarker for Survival in Amyotrophic Lateral Sclerosis
. Am J Respir Crit Care Med
. 2017
Jan
;195
(1
):86
–95
.
[PubMed]
1073-449X13.
Capozzo
R
, Quaranta
VN
, Pellegrini
F
, Fontana
A
, Copetti
M
, Carratù
P
, et al Sniff nasal inspiratory pressure as a prognostic factor of tracheostomy or death in amyotrophic lateral sclerosis
. J Neurol
. 2015
Mar
;262
(3
):593
–603
.
[PubMed]
0340-535414.
Bauer
M
, Czell
D
, Hartmann
S
, Goldman
B
, Müller
D
, Weber
M
. Limitations of sniff nasal pressure as an outcome measurement in amyotrophic lateral sclerosis patients in a clinical trial
. Respiration
. 2012
;84
(4
):306
–11
.
[PubMed]
1423-035615.
Lofaso
F
, Nicot
F
, Lejaille
M
, Falaize
L
, Louis
A
, Clement
A
, et al Sniff nasal inspiratory pressure: what is the optimal number of sniffs?
Eur Respir J
. 2006
May
;27
(5
):980
–2
.
[PubMed]
0903-193616.
Fitting
JW
, Paillex
R
, Hirt
L
, Aebischer
P
, Schluep
M
. Sniff nasal pressure: a sensitive respiratory test to assess progression of amyotrophic lateral sclerosis
. Ann Neurol
. 1999
Dec
;46
(6
):887
–93
.
[PubMed]
0364-513417.
Stefanutti
D
, Benoist
MR
, Scheinmann
P
, Chaussain
M
, Fitting
JW
. Usefulness of sniff nasal pressure in patients with neuromuscular or skeletal disorders
. Am J Respir Crit Care Med
. 2000
Oct
;162
(4 Pt 1
):1507
–11
.
[PubMed]
1073-449X18.
Prigent
H
, Lejaille
M
, Falaize
L
, Louis
A
, Ruquet
M
, Fauroux
B
, et al Assessing inspiratory muscle strength by sniff nasal inspiratory pressure
. Neurocrit Care
. 2004
;1
(4
):475
–8
.
[PubMed]
1541-693319.
Mustfa
N
, Moxham
J
. Respiratory muscle assessment in motor neurone disease
. QJM
. 2001
Sep
;94
(9
):497
–502
.
[PubMed]
1460-272520.
Steier
J
, Kaul
S
, Seymour
J
, Jolley
C
, Rafferty
G
, Man
W
, et al The value of multiple tests of respiratory muscle strength
. Thorax
. 2007
Nov
;62
(11
):975
–80
.
[PubMed]
0040-637621.
Chaudri
MB
, Liu
C
, Watson
L
, Jefferson
D
, Kinnear
WJ
. Sniff nasal inspiratory pressure as a marker of respiratory function in motor neuron disease
. Eur Respir J
. 2000
Mar
;15
(3
):539
–42
.
[PubMed]
0903-193622.
Brooks
BR
, Miller
RG
, Swash
M
, Munsat
TL
; World Federation of Neurology Research Group on Motor Neuron Diseases
. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis
. Amyotroph Lateral Scler Other Motor Neuron Disord
. 2000
Dec
;1
(5
):293
–9
.
[PubMed]
1466-082223.
Miller
MR
, Hankinson
J
, Brusasco
V
, Burgos
F
, Casaburi
R
, Coates
A
, et al; ATS/ERS Task Force
. Standardisation of spirometry
. Eur Respir J
. 2005
Aug
;26
(2
):319
–38
.
[PubMed]
0903-193624.
American Thoracic Society/European Respiratory Society
. ATS/ERS Statement on respiratory muscle testing
. Am J Respir Crit Care Med
. 2002
Aug
;166
(4
):518
–624
.
[PubMed]
1073-449X25.
Koulouris
N
, Mulvey
DA
, Laroche
CM
, Sawicka
EH
, Green
M
, Moxham
J
. The measurement of inspiratory muscle strength by sniff esophageal, nasopharyngeal, and mouth pressures
. Am Rev Respir Dis
. 1989
Mar
;139
(3
):641
–6
.
[PubMed]
0003-080526.
Héritier
F
, Rahm
F
, Pasche
P
, Fitting
JW
. Sniff nasal inspiratory pressure. A noninvasive assessment of inspiratory muscle strength
. Am J Respir Crit Care Med
. 1994
Dec
;150
(6 Pt 1
):1678
–83
.
[PubMed]
1073-449X27.
Hamnegård
CH
, Wragg
S
, Kyroussis
D
, Aquilina
R
, Moxham
J
, Green
M
. Portable measurement of maximum mouth pressures
. Eur Respir J
. 1994
Feb
;7
(2
):398
–401
.
[PubMed]
0903-193628.
Shrout
PE
, Fleiss
JL
. Intraclass correlations: uses in assessing rater reliability
. Psychol Bull
. 1979
Mar
;86
(2
):420
–8
.
[PubMed]
0033-290929.
Bland
JM
, Altman
DG
. Statistical methods for assessing agreement between two methods of clinical measurement
. Lancet
. 1986
Feb
;1
(8476
):307
–10
.
[PubMed]
0140-673630.
Carratù
P
, Cassano
A
, Gadaleta
F
, Tedone
M
, Dongiovanni
S
, Fanfulla
F
, et al Association between low sniff nasal-inspiratory pressure (SNIP) and sleep disordered breathing in amyotrophic lateral sclerosis: preliminary results
. Amyotroph Lateral Scler
. 2011
Nov
;12
(6
):458
–63
.
[PubMed]
1748-296831.
Schmidt
EP
, Drachman
DB
, Wiener
CM
, Clawson
L
, Kimball
R
, Lechtzin
N
. Pulmonary predictors of survival in amyotrophic lateral sclerosis: use in clinical trial design
. Muscle Nerve
. 2006
Jan
;33
(1
):127
–32
.
[PubMed]
0148-639X32.
Hughes
PD
, Polkey
MI
, Kyroussis
D
, Hamnegard
CH
, Moxham
J
, Green
M
. Measurement of sniff nasal and diaphragm twitch mouth pressure in patients
. Thorax
. 1998
Feb
;53
(2
):96
–100
.
[PubMed]
0040-637633.
Maillard
JO
, Burdet
L
, van Melle
G
, Fitting
JW
. Reproducibility of twitch mouth pressure, sniff nasal inspiratory pressure, and maximal inspiratory pressure
. Eur Respir J
. 1998
Apr
;11
(4
):901
–5
.
[PubMed]
0903-193634.
Hart
N
, Polkey
MI
, Sharshar
T
, Falaize
L
, Fauroux
B
, Raphaël
JC
, et al Limitations of sniff nasal pressure in patients with severe neuromuscular weakness
. J Neurol Neurosurg Psychiatry
. 2003
Dec
;74
(12
):1685
–7
.
[PubMed]
0022-305035.
Terzi
N
, Orlikowski
D
, Fermanian
C
, Lejaille
M
, Falaize
L
, Louis
A
, et al Measuring inspiratory muscle strength in neuromuscular disease: one test or two?
Eur Respir J
. 2008
Jan
;31
(1
):93
–8
.
[PubMed]
0903-193636.
Uldry
C
, Fitting
JW
. Maximal values of sniff nasal inspiratory pressure in healthy subjects
. Thorax
. 1995
Apr
;50
(4
):371
–5
.
[PubMed]
0040-637637.
Nava
S
, Ambrosino
N
, Crotti
P
, Fracchia
C
, Rampulla
C
. Recruitment of some respiratory muscles during three maximal inspiratory manoeuvres
. Thorax
. 1993
Jul
;48
(7
):702
–7
.
[PubMed]
0040-6376© 2019 S. Karger AG, Basel
2019
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
